CD274 and neoplasm: We speculate that the lack of efficacy in our study may be related to the modest ANC reductions (few of which were <0.5 or <1 × 109/L), which may have been insufficient to overcome MDSC activity in the tumor microenvironment and tumor resistance to anti–PD-(L)1 treatment.